Sources & Methodology

Sources & Methodology

This page explains how ADHD Insurance researches, sources, and maintains the information on this website. Our goal is to be transparent about where content comes from, how it is checked, and how we keep material up to date — particularly for topics where insurance rules, clinical guidance, and laws change frequently.

Who produces our content

Standard identity: [Site Name] Editorial Team.

The editorial team researches, writes, and maintains informational content for this website. Content is produced and edited by our staff and contributors using the processes described below. When material requires clinical, legal, or specialized insurance interpretation, we rely on primary public sources and, when necessary, outside reviewers with relevant, verifiable expertise.

Editorial standards

  • Accuracy: We aim to reflect the best available public evidence and official documentation for insurance rules, clinical guidance, and policy developments.
  • Transparency: Articles include links to original sources whenever possible and note the date a source was accessed.
  • Clarity: We summarize complex insurance and clinical topics in plain language, while linking to primary sources for readers who want full details.
  • Neutrality: Our editorial decisions are independent of advertisers and sponsors; sponsored content is clearly labeled and separated from editorial content.

Research process

Typical research steps for a topic on this site:

  1. Define the question (for example: “Does Carriers’ plan X cover stimulant medication for adults?”).
  2. Search for primary sources: insurer documents (Evidence of Coverage, medical policy), government guidance, clinical practice guidelines, and peer-reviewed publications.
  3. Prioritize primary and official documents over summaries — for legal or coverage questions, we prefer direct insurer policies, state law texts, or federal agency pages.
  4. Cross-check findings against multiple reputable sources when possible.
  5. Draft content with clear citations and reviewer notes; if interpretation is required, consult external subject-matter reviewers or include qualifying language.

Preferred source types

We prioritize the following source types, in roughly this order of preference for factual claims about coverage, clinical recommendations, or regulatory requirements:

  • Official insurer documents (Evidence of Coverage, Summary of Benefits and Coverage, formulary pages, prior authorization and medical necessity criteria).
  • Government and public agency sources (federal and state agencies listed below).
  • Clinical practice guidelines from recognized professional organizations.
  • Peer-reviewed research, systematic reviews, and meta-analyses for clinical or effectiveness claims.
  • Public statutes and regulations (state insurance codes, federal statutes such as mental health parity provisions) and court decisions where relevant.
  • Data from public datasets and registries (for example, CMS or state Medicaid reports) when citing utilization or coverage trends.
  • Reputable news outlets and academic press for reporting on policy changes, with links to the underlying official documents when available.

Official and public data sources we commonly use

  • Federal agencies: Centers for Medicare & Medicaid Services (CMS), Food and Drug Administration (FDA), National Institutes of Health (NIH), National Institute of Mental Health (NIMH), Substance Abuse and Mental Health Services Administration (SAMHSA), and Centers for Disease Control and Prevention (CDC).
  • State agencies: State Medicaid agencies and state departments of insurance for state-specific coverage rules and parity guidance.
  • Professional associations and clinical guideline publishers (for example, pediatric and psychiatric associations) for guidance on diagnosis and treatment standards.
  • Insurer policy manuals, formularies, and published medical necessity criteria (Evidence of Coverage, Summary of Benefits, medical policy pages).

Industry and technical references

For insurance-specific topics we consult:

  • Policy documents and plan contracts (Evidence of Coverage, Summary of Benefits and Coverage).
  • Medical policy and prior authorization criteria issued by carriers.
  • State and federal statutes and regulations that affect coverage (for example, mental health parity laws and Medicaid coverage rules).
  • Regulatory guidance from insurance departments and CMS.

Source selection and citation practices

  • We link to the source when it is publicly available online and include the date the source was accessed.
  • When summarizing an insurer’s policy, we link to the specific policy document or the insurer’s published guidance where possible.
  • If a primary document is not publicly available (for example, internal insurer documents), we note the limitation and rely on secondary authoritative sources or contact the issuer for clarification when feasible.
  • We indicate when a claim is based on expert interpretation rather than explicit language in primary documents.

Fact checking

Fact-checking steps include:

  • Verifying quoted policy language against the original document and noting section references or URLs.
  • Cross-referencing claims with at least one other reputable source whenever possible.
  • Asking for clarification from the issuing organization (insurer, agency) when language is ambiguous and it materially affects readers.
  • Reviewing clinical claims against current clinical guidelines and peer-reviewed evidence.

AI assistance disclosure

We sometimes use AI tools to help with drafting, summarizing large documents, formatting, and identifying potentially relevant sources. Any content drafted or assisted by AI is reviewed, edited, and verified by human editors before publication. AI is used as an aid to human researchers and editors — not as a substitute for verification from primary sources or qualified reviewers.

Human and editorial review

  • All articles are reviewed by at least one editor for accuracy, clarity, and sourcing before publication.
  • For articles that involve clinical interpretation, legal questions, or insurer-specific determinations, editors will seek input from qualified external reviewers or cite official guidance. When external reviewers are consulted, we disclose that fact in the article or a reviewer note where appropriate.
  • Editors document major sources and review steps internally so future updates can be made efficiently and transparently.

Content updates and review schedule

Because insurance rules, clinical guidance, and regulations change, we review and update content on a scheduled and event-driven basis:

  • Scheduled reviews: Core resource pages and guides are reviewed at least once every 12 months.
  • Event-driven updates: When an important law, insurer policy, clinical guideline, or FDA label changes, we prioritize updating affected pages as soon as possible.
  • Readers can see the “last reviewed” or “last updated” date on articles when significant changes are made; minor copy edits may not always change an article’s timestamp.

Corrections policy

If you believe a page contains inaccurate or misleading information, please let us know using our Contact page. We commit to:

  • Investigating reported errors promptly.
  • Responding to reports and acknowledging receipt.
  • Making corrections when warranted and noting substantive corrections on the page or in the article’s revision history.

Contact us to report corrections: https://adhdinsurance.com/contact

Independence and advertising

Advertising and sponsored content are kept separate from editorial content. Advertisements are labeled as such. Sponsors and advertisers do not determine editorial topics, influence coverage decisions, or review articles prior to publication. When content is sponsored or paid for, the relationship is disclosed on the relevant page.

Author and byline approach

  • Bylines indicate the author or primary contributor and often include a short role description (for example, “Editor” or “Staff Writer”).
  • When subject-matter experts or outside reviewers contribute substantially, we note their involvement in a reviewer or contributor line.
  • When articles are produced by the editorial team without a named individual, we list the author as “[Site Name] Editorial Team.”

How we handle medical, legal, and financial topics

Content on ADHD Insurance is informational and is intended to help readers understand insurance coverage, clinical guidance, and policy changes related to ADHD and mental health. We do not provide medical, legal, or financial advice. For personalized advice about diagnosis, treatment options, insurance benefits, or legal rights, consult a qualified clinician, insurance representative, or attorney.

Common examples of how we use sources for ADHD insurance topics

  • Coverage for ADHD medication: we cite insurer formularies, medical necessity criteria, and FDA labeling where relevant.
  • Therapy and behavioral interventions: we reference clinical practice guidelines and insurer coverage policies to describe typical benefit structures and limitations.
  • Telehealth and remote care: we reference state telehealth rules, insurer telehealth policies, and federal guidance impacting coverage.
  • Medicaid and public programs: we use state Medicaid manuals, CMS guidance, and state department resources for program-specific details.

Final note

We strive to make this site a reliable, up-to-date resource for people navigating ADHD and insurance topics. If something seems unclear or incomplete, please contact us through our Contact page and include links or documents that can help us verify and improve the content.

Leave a Comment